The expression of EGR1 in gliomas has previously been investigated by Sakakini et al. 14 and Mittelbronn et al. 26, who found EGR1 expression in 82% and 100% of tumours respectively, which is similar to our findings of expression in all 207 investigated tumours. Here, EGR1 is linked to central nervous system cancer.